Comments
Loading...

Cartesian Therapeutics

RNACNASDAQ
Logo brought to you by Benzinga Data
$16.93
-2.85-14.41%
At close: -
$17.77
0.844.96%
After Hours: 4:10 PM EDT
Q3 2024 Earnings were released on Thu Nov 7th, before the market open

Cartesian Therapeutics (NASDAQ:RNAC) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Cartesian Therapeutics (RNAC)?

A

There have been no specific sales or earnings guidance reported for Cartesian Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch